Analysts Issue Forecasts for Evaxion Biotech A/S’s Q2 2024 Earnings (NASDAQ:EVAX)

Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) – Stock analysts at Zacks Small Cap issued their Q2 2024 EPS estimates for shares of Evaxion Biotech A/S in a report released on Tuesday, July 30th. Zacks Small Cap analyst B. Sorensen anticipates that the company will earn $0.02 per share for the quarter. The consensus estimate […]

Leave a Reply

Your email address will not be published.

Previous post Canaccord Genuity Group Raises Automotive Properties Real Est Invt TR (TSE:APR.UN) Price Target to C$12.50
Next post Seaport Res Ptn Brokers Lower Earnings Estimates for Targa Resources Corp. (NYSE:TRGP)